Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach
Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This study defines and illustrates the ESPD strategy f...
Saved in:
Published in | Frontiers in pharmacology Vol. 14; p. 1255021 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
30.10.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1663-9812 1663-9812 |
DOI | 10.3389/fphar.2023.1255021 |
Cover
Abstract | Background:
Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This study defines and illustrates the ESPD strategy for censored data.
Methods:
The ESPD approach assumes that events are generated through a two-step process. First, the type of event is selected according to some (unknown) mixture proportions. Next, the times of occurrence of the events are sampled from a corresponding survival distribution. Both of these steps can be modelled based on covariates. Performance was evaluated through a simulation study, considering sample size and levels of censoring. Additionally, an oncology-related case study was conducted to assess the ability to produce realistic results, and to demonstrate its implementation using both frequentist and Bayesian frameworks in R.
Results:
The simulation study showed good performance of the ESPD approach, with accuracy decreasing as sample sizes decreased and censoring levels increased. The average relative absolute error of the event probability (95%-confidence interval) ranged from 0.04 (0.00; 0.10) to 0.23 (0.01; 0.66) for 60% censoring and sample size 50, showing that increased censoring and decreased sample size resulted in lower accuracy. The approach yielded realistic results in the case study.
Discussion:
The ESPD approach can be used to model competing events in DES based on censored data. Further research is warranted to compare the approach to other modelling approaches for DES, and to evaluate its usefulness in estimating cumulative event incidences in a broader context. |
---|---|
AbstractList | Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This study defines and illustrates the ESPD strategy for censored data.Methods: The ESPD approach assumes that events are generated through a two-step process. First, the type of event is selected according to some (unknown) mixture proportions. Next, the times of occurrence of the events are sampled from a corresponding survival distribution. Both of these steps can be modelled based on covariates. Performance was evaluated through a simulation study, considering sample size and levels of censoring. Additionally, an oncology-related case study was conducted to assess the ability to produce realistic results, and to demonstrate its implementation using both frequentist and Bayesian frameworks in R.Results: The simulation study showed good performance of the ESPD approach, with accuracy decreasing as sample sizes decreased and censoring levels increased. The average relative absolute error of the event probability (95%-confidence interval) ranged from 0.04 (0.00; 0.10) to 0.23 (0.01; 0.66) for 60% censoring and sample size 50, showing that increased censoring and decreased sample size resulted in lower accuracy. The approach yielded realistic results in the case study.Discussion: The ESPD approach can be used to model competing events in DES based on censored data. Further research is warranted to compare the approach to other modelling approaches for DES, and to evaluate its usefulness in estimating cumulative event incidences in a broader context. Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This study defines and illustrates the ESPD strategy for censored data. Methods: The ESPD approach assumes that events are generated through a two-step process. First, the type of event is selected according to some (unknown) mixture proportions. Next, the times of occurrence of the events are sampled from a corresponding survival distribution. Both of these steps can be modelled based on covariates. Performance was evaluated through a simulation study, considering sample size and levels of censoring. Additionally, an oncology-related case study was conducted to assess the ability to produce realistic results, and to demonstrate its implementation using both frequentist and Bayesian frameworks in R. Results: The simulation study showed good performance of the ESPD approach, with accuracy decreasing as sample sizes decreased and censoring levels increased. The average relative absolute error of the event probability (95%-confidence interval) ranged from 0.04 (0.00; 0.10) to 0.23 (0.01; 0.66) for 60% censoring and sample size 50, showing that increased censoring and decreased sample size resulted in lower accuracy. The approach yielded realistic results in the case study. Discussion: The ESPD approach can be used to model competing events in DES based on censored data. Further research is warranted to compare the approach to other modelling approaches for DES, and to evaluate its usefulness in estimating cumulative event incidences in a broader context. Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This study defines and illustrates the ESPD strategy for censored data. Methods: The ESPD approach assumes that events are generated through a two-step process. First, the type of event is selected according to some (unknown) mixture proportions. Next, the times of occurrence of the events are sampled from a corresponding survival distribution. Both of these steps can be modelled based on covariates. Performance was evaluated through a simulation study, considering sample size and levels of censoring. Additionally, an oncology-related case study was conducted to assess the ability to produce realistic results, and to demonstrate its implementation using both frequentist and Bayesian frameworks in R. Results: The simulation study showed good performance of the ESPD approach, with accuracy decreasing as sample sizes decreased and censoring levels increased. The average relative absolute error of the event probability (95%-confidence interval) ranged from 0.04 (0.00; 0.10) to 0.23 (0.01; 0.66) for 60% censoring and sample size 50, showing that increased censoring and decreased sample size resulted in lower accuracy. The approach yielded realistic results in the case study. Discussion: The ESPD approach can be used to model competing events in DES based on censored data. Further research is warranted to compare the approach to other modelling approaches for DES, and to evaluate its usefulness in estimating cumulative event incidences in a broader context.Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This study defines and illustrates the ESPD strategy for censored data. Methods: The ESPD approach assumes that events are generated through a two-step process. First, the type of event is selected according to some (unknown) mixture proportions. Next, the times of occurrence of the events are sampled from a corresponding survival distribution. Both of these steps can be modelled based on covariates. Performance was evaluated through a simulation study, considering sample size and levels of censoring. Additionally, an oncology-related case study was conducted to assess the ability to produce realistic results, and to demonstrate its implementation using both frequentist and Bayesian frameworks in R. Results: The simulation study showed good performance of the ESPD approach, with accuracy decreasing as sample sizes decreased and censoring levels increased. The average relative absolute error of the event probability (95%-confidence interval) ranged from 0.04 (0.00; 0.10) to 0.23 (0.01; 0.66) for 60% censoring and sample size 50, showing that increased censoring and decreased sample size resulted in lower accuracy. The approach yielded realistic results in the case study. Discussion: The ESPD approach can be used to model competing events in DES based on censored data. Further research is warranted to compare the approach to other modelling approaches for DES, and to evaluate its usefulness in estimating cumulative event incidences in a broader context. |
Author | IJzerman, Maarten J. Franchini, Fanny Fedyashov, Victor Degeling, Koen |
AuthorAffiliation | 3 ARC Training Centre in Cognitive Computing for Medical Technologies , The University of Melbourne , Parkville , VIC , Australia 1 Cancer Health Services Research , Centre for Health Policy , Melbourne School of Population and Global Health , Faculty of Medicine , Dentistry and Health Sciences , The University of Melbourne , Melbourne , VIC , Australia 5 Erasmus School of Health Policy & Management , Erasmus University , Rotterdam , Netherlands 4 Department of Cancer Research , Peter MacCallum Cancer Centre , Melbourne , Australia 2 Cancer Health Services Research , Centre for Cancer Research , Faculty of Medicine , Dentistry and Health Sciences , The University of Melbourne , Melbourne , VIC , Australia |
AuthorAffiliation_xml | – name: 2 Cancer Health Services Research , Centre for Cancer Research , Faculty of Medicine , Dentistry and Health Sciences , The University of Melbourne , Melbourne , VIC , Australia – name: 4 Department of Cancer Research , Peter MacCallum Cancer Centre , Melbourne , Australia – name: 1 Cancer Health Services Research , Centre for Health Policy , Melbourne School of Population and Global Health , Faculty of Medicine , Dentistry and Health Sciences , The University of Melbourne , Melbourne , VIC , Australia – name: 3 ARC Training Centre in Cognitive Computing for Medical Technologies , The University of Melbourne , Parkville , VIC , Australia – name: 5 Erasmus School of Health Policy & Management , Erasmus University , Rotterdam , Netherlands |
Author_xml | – sequence: 1 givenname: Fanny surname: Franchini fullname: Franchini, Fanny – sequence: 2 givenname: Victor surname: Fedyashov fullname: Fedyashov, Victor – sequence: 3 givenname: Maarten J. surname: IJzerman fullname: IJzerman, Maarten J. – sequence: 4 givenname: Koen surname: Degeling fullname: Degeling, Koen |
BookMark | eNp9kUuPFCEUhStmTBzH-QOuaummWl4FhRtjJj46mcSNrgkFl27GKiiB6sR_L_0wmZmFbLi5nPMB97xurkIM0DRvMdpQOsj3btnrtCGI0A0mfY8IftFcY85pJwdMrh7Vr5rbnB9QXVRKytl1c9jOywQzhOLDrjVxXuBUJZ9_5daH1vpsEhRo4VBFbfbzOuniY_jQlv2l2-UFjHfetEuKox795IuH3Opgj_6S_LgeLbWzVIU2-zfNS6enDLeX_ab5-eXzj7tv3f33r9u7T_edYYyXzlqhhcZjLwk3oidcCGb6EYxDWHPEMCXSYsa06THtncNI9nYADU5IYamjN832zLVRP6gl-VmnPypqr06NmHZKp-LNBMoiDqMxmNZLmZBk4AKDFbSyEBHcVtbHM2tZxxmsqR9PenoCfXoS_F7t4kFhxFklyEp4dyGk-HuFXNRcpwvTpAPENSsySEQ5YRxX6XCWmhRzTuCU8eU094r2U2WqY_bqlL06Zq8u2VcreWb998T_mP4CZsa5jA |
CitedBy_id | crossref_primary_10_1016_j_jval_2024_06_006 |
Cites_doi | 10.1007/978-1-4612-4348-9 10.1007/s40273-014-0183-5 10.1177/0272989X12455462 10.1002/sim.4384 10.1057/jos.2009.25 10.1007/s00180-010-0217-1 10.1093/aje/kwp107 10.1002/sim.7501 10.3310/hta8110 10.1002/9780470870709 10.1016/j.jval.2021.07.016 10.1080/01621459.1999.10474144 10.1177/0272989X12455463 10.1177/0272989X18814770 10.3390/ijerph182212262 10.1016/j.jval.2012.04.014 10.1136/bmj-2022-071349 10.1214/aoms/1177729694 10.1016/j.jval.2020.01.016 |
ContentType | Journal Article |
Copyright | Copyright © 2023 Franchini, Fedyashov, IJzerman and Degeling. Copyright © 2023 Franchini, Fedyashov, IJzerman and Degeling. 2023 Franchini, Fedyashov, IJzerman and Degeling |
Copyright_xml | – notice: Copyright © 2023 Franchini, Fedyashov, IJzerman and Degeling. – notice: Copyright © 2023 Franchini, Fedyashov, IJzerman and Degeling. 2023 Franchini, Fedyashov, IJzerman and Degeling |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fphar.2023.1255021 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Franchini et al |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_d06ebcc13dd747928671ed73ef70276d PMC10642769 10_3389_fphar_2023_1255021 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c446t-dd7a7a1b5926c7526774c5becf01a6041329d144ac5135ff1095d8eaef797d3f3 |
IEDL.DBID | DOA |
ISSN | 1663-9812 |
IngestDate | Wed Aug 27 01:26:47 EDT 2025 Thu Aug 21 18:36:23 EDT 2025 Fri Sep 05 13:40:24 EDT 2025 Tue Jul 01 02:53:17 EDT 2025 Thu Apr 24 23:08:50 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c446t-dd7a7a1b5926c7526774c5becf01a6041329d144ac5135ff1095d8eaef797d3f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Blythe Adamson, Flatiron Health, United States Jim Nutaro, Oak Ridge National Laboratory (DOE), United States Reviewed by: Faiz Ahmed Mohamed Elfaki, Qatar University, Qatar These authors have contributed equally to this work and share first authorship |
OpenAccessLink | https://doaj.org/article/d06ebcc13dd747928671ed73ef70276d |
PQID | 2890362461 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d06ebcc13dd747928671ed73ef70276d pubmedcentral_primary_oai_pubmedcentral_nih_gov_10642769 proquest_miscellaneous_2890362461 crossref_citationtrail_10_3389_fphar_2023_1255021 crossref_primary_10_3389_fphar_2023_1255021 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-10-30 |
PublicationDateYYYYMMDD | 2023-10-30 |
PublicationDate_xml | – month: 10 year: 2023 text: 2023-10-30 day: 30 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in pharmacology |
PublicationYear | 2023 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Ripley (B21) 2022 Degeling (B9) 2022; 25 Češnovar (B6) 2022 Degeling (B10) 2019; 39 Lau (B18) 2009; 170 Siebert (B22) 2012; 15 Austin (B2) 2017; 36 Kullback (B17) 1951; 22 Marshall (B19) 2020; 23 Günal (B12) 2017; 4 Henningsen (B13) 2010; 26 Hinkley (B14) 1997 Koller (B16) 2012; 31 Karnon (B15) 2012; 32 Pintilie (B20) 2006 Coemans (B7) 2022; 378 Cover (B8) 1999 Barton (B3) 2004; 8 Team (B23) 2023 Andersen (B1) 1993 Caro (B5) 2014; 32 Fine (B11) 1999; 94 Vazquez-Serrano (B24) 2021; 18 Briggs (B4) 2012; 15 |
References_xml | – volume-title: Bootstrap methods and their applications year: 1997 ident: B14 – volume-title: RStan: the R interface to Stan year: 2023 ident: B23 – volume-title: Statistical models based on counting processes year: 1993 ident: B1 doi: 10.1007/978-1-4612-4348-9 – volume-title: Boot: bootstrap R (S-plus) functions year: 2022 ident: B21 – volume: 32 start-page: 943 year: 2014 ident: B5 article-title: Decision-analytic models: current methodological challenges publication-title: Pharmacoeconomics doi: 10.1007/s40273-014-0183-5 – volume-title: Elements of information theory year: 1999 ident: B8 – volume: 32 start-page: 701 year: 2012 ident: B15 article-title: Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force–4 publication-title: Med. Decis. Mak. doi: 10.1177/0272989X12455462 – volume: 31 start-page: 1089 year: 2012 ident: B16 article-title: Competing risks and the clinical community: irrelevance or ignorance? publication-title: Stat. Med. doi: 10.1002/sim.4384 – volume: 4 start-page: 42 year: 2017 ident: B12 article-title: Discrete event simulation for performance modelling in health care: a review of the literature publication-title: J. Simul. doi: 10.1057/jos.2009.25 – volume-title: Cmdstanr: R interface to 'CmdStan year: 2022 ident: B6 – volume: 26 start-page: 443 year: 2010 ident: B13 article-title: maxLik: a package for maximum likelihood estimation in R publication-title: Comput. Stat. doi: 10.1007/s00180-010-0217-1 – volume: 170 start-page: 244 year: 2009 ident: B18 article-title: Competing risk regression models for epidemiologic data publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwp107 – volume: 36 start-page: 4391 year: 2017 ident: B2 article-title: Practical recommendations for reporting Fine-Gray model analyses for competing risk data publication-title: Stat. Med. doi: 10.1002/sim.7501 – volume: 8 start-page: 1 year: 2004 ident: B3 article-title: The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis publication-title: Health Technol. Assess. Winch. Engl. doi: 10.3310/hta8110 – volume-title: Competing risks: a practical perspective year: 2006 ident: B20 doi: 10.1002/9780470870709 – volume: 25 start-page: 104 year: 2022 ident: B9 article-title: Comparing modeling approaches for discrete event simulations with competing risks based on censored individual patient data: a simulation study and illustration in colorectal cancer publication-title: Value Health doi: 10.1016/j.jval.2021.07.016 – volume: 94 start-page: 496 year: 1999 ident: B11 article-title: A proportional hazards model for the subdistribution of a competing risk publication-title: J. Am. Stat. Assoc. doi: 10.1080/01621459.1999.10474144 – volume: 15 start-page: 690 year: 2012 ident: B22 article-title: State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3 publication-title: Value Health doi: 10.1177/0272989X12455463 – volume: 39 start-page: 57 year: 2019 ident: B10 article-title: Comparing strategies for modeling competing risks in discrete-event simulations: a simulation study and illustration in colorectal cancer publication-title: Med. Decis. Mak. doi: 10.1177/0272989X18814770 – volume: 18 start-page: 12262 year: 2021 ident: B24 article-title: Discrete-event simulation modeling in healthcare: a comprehensive review publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph182212262 – volume: 15 start-page: 835 year: 2012 ident: B4 article-title: Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6 publication-title: Value Health doi: 10.1016/j.jval.2012.04.014 – volume: 378 start-page: e071349 year: 2022 ident: B7 article-title: Bias by censoring for competing events in survival analysis publication-title: BMJ doi: 10.1136/bmj-2022-071349 – volume: 22 start-page: 79 year: 1951 ident: B17 article-title: On information and sufficiency publication-title: Ann. Math. Statistics doi: 10.1214/aoms/1177729694 – volume: 23 start-page: 566 year: 2020 ident: B19 article-title: Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling publication-title: Value Health doi: 10.1016/j.jval.2020.01.016 |
SSID | ssj0000399364 |
Score | 2.3458884 |
Snippet | Background:
Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific... Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1255021 |
SubjectTerms | bayesian framework censored data competing risks modelling discrete event simulation frequentist implementation Pharmacology |
SummonAdditionalLinks | – databaseName: Scholars Portal: Open Access Journals [open access] dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS9xAFB5EL71IaytubcsUyl40Nsn8SFIQaUtlKVQ8uOBtmMwPXVizullL97_ve5PZ1YD21FuYzJBMXibv-zLvfY-QT9Z65l1pklJ6nnAJBKVG2UrBhLO-FNrV-L_j15kcjfnPS3G5QVbljuIDbJ-kdlhPajyfHv25W57Agj9Gxgn-9rO_vdYo7ZmzI3DXIsW88q2wX4ShfBHuhy8zemPJu9yZZ4b2_FOQ8e9hz37k5CNXdPqSbEcMSb92Rn9FNlyzQ4bnnQj18pBePORUtYd0SM8f5KmXr8nvIAgcooSaK2oCbsYjDDJv6aShmKg7ByxNg7gTbSc3scTXFwposWtNMEMTo4woVqTptL6Bc1PdWBy_LqMFLVG0_A0Zn_64-D5KYvWFxABFXCTWFrrQWS2qXJpC5BKAohFgcp9mWqYcK9RboGPaiIwJ7zMAa7Z02vmiKizzbJdsNrPG7RHKUidKwAY1l5pXngMG0TbNtZc81blzA5KtnrkyUZocK2RMFVAUtJMKdlJoJxXtNCAH6zG3nTDHP3t_Q1Oue6KodmiYza9UXKPKptLVxmQMps6LKkfpP2cLBjMC8i7tgHxcvQgKFiHurOjGze5bhbu1gAS4hAuVvTekd8X-mWZyHeS8M-SAhaze_o973CcvcN7Bu6bvyOZifu_eA2xa1B_CWvgLFoUcKw priority: 102 providerName: Scholars Portal |
Title | Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach |
URI | https://www.proquest.com/docview/2890362461 https://pubmed.ncbi.nlm.nih.gov/PMC10642769 https://doaj.org/article/d06ebcc13dd747928671ed73ef70276d |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYv4xPVFBPGi1bR5tPWmoiyC4kHBW0jz0AXtirsK_ntn0u66vejFSylpStvMpPN97eQbQvadCzz4wiaFCiIRCghKhbKVkkvvQiGNr_B7x82t6j-I60f5OFPqC3PCGnngZuBOHFO-sjblzgHyLTPUY_Mu5z7kwKiUw7cvK9kMmYrvYIy7SjSrZICFlSfh7dmg_mfGjyGmS5alnUgUBfs7KLObIzkTdK6WyGKLFulZc5fLZM7XK-TgrpGb_jqi9z-rp0ZH9IDe_QhRf62Szyj9G_OB6idqI0LGPUwnH9FBTXFJ7jugZhplnOho8NoW8zqlgAub1gTXYmI-EcXaM42qN7BramqH508LZkFLK0--Rh6uLu8v-klbZyGxQAbHCYysyU1ayTJTNpeZAkhoJRg3sNQoJrAWvQPiZaxMuQwhBVjmCm_ABGXueODrZL4e1n6DUM68LAAFVEIZUQYBaMM4lpmgBDOZ9z2STsZc21aEHGthvGggI2gnHe2k0U66tVOPHE7PeWskOH7tfY6mnPZE-ezYAE6lW6fSfzlVj-xNHEHDdMN_KKb2w4-Rxv-yEPOFggsVHQ_pXLF7pB48R-HuFNlersrN_7jHLbKAzx3jKNsm8-P3D78DAGlc7ca5ANsbUXwDtEwUoQ |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Implementing+competing+risks+in+discrete+event+simulation%3A+the+event-specific+probabilities+and+distributions+approach&rft.jtitle=Frontiers+in+pharmacology&rft.au=Fanny+Franchini&rft.au=Fanny+Franchini&rft.au=Victor+Fedyashov&rft.au=Maarten+J.+IJzerman&rft.date=2023-10-30&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=14&rft_id=info:doi/10.3389%2Ffphar.2023.1255021&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_d06ebcc13dd747928671ed73ef70276d |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |